The Enterprise Value as of May 2026 (TTM) for Newron Pharmaceuticals S.p.A. (NP5.DE) is 357.45M

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 357.45M. This represents a change of 25.77% compared to the average of 284.21M of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NP5.DE) Historical Enterprise Value (quarterly & annually)

How has NP5.DE Enterprise Value performed in the past?

The mean historical Enterprise Value of Newron Pharmaceuticals S.p.A. over the last ten years is 157.07M. The current 357.45M Enterprise Value has changed 22.66% with respect to the historical average. Over the past ten years (40 quarters), NP5.DE's Enterprise Value was at its highest in in the December 2025 quarter at 537.26M. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Newron Pharmaceuticals S.p.A. (NP5.DE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newron Pharmaceuticals S.p.A. (NP5.DE) Average Enterprise Value

How has NP5.DE Enterprise Value performed in the past?

The current Enterprise Value of Newron Pharmaceuticals S.p.A. (NP5.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Newron Pharmaceuticals S.p.A. (NP5.DE) Enterprise Value vs. Peers

How is NP5.DE’s Enterprise Value compared to its peers?

Newron Pharmaceuticals S.p.A.’s Enterprise Value is less than Medios AG (432.82M), greater than M1 Kliniken AG (344.92M), greater than Stratec SE (299.64M), greater than High Tide Inc. (355.31M), greater than Formycon AG (308.31M), less than Mediclin AG (487.75M), greater than Zura Bio Limited (43.60M), greater than DocCheck AG (67.31M), greater than Geratherm Medical AG (9.97M), greater than Heidelberg Pharma AG (118.07M),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NP5.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NP5.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.